Enzo Biochem Inc (EZB F) stock market data APIs
€0.3845
0(0%)
as of June 12, 2025
Try our APIs with
free plan!
Enzo Biochem Inc Financial Data Overview
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Prev. Close
0.3845
Open
0.3845
High
0.3845
Low
0.3845
52 wk Range
0.01-1.01
Market Cap
26 542 K
Shares Outstanding
52 403 K
Revenue
29 094 K
Dividends (Yield)
0.9778
Beta
1.141
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enzo Biochem Inc data using free add-ons & libraries
Get Enzo Biochem Inc Fundamental Data
Enzo Biochem Inc Fundamental data includes:
- Net Revenue: 29 094 K
- EBITDA: -8 564 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enzo Biochem Inc News
New
Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)
Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, investment in the fund re...
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Enzo Biochem, Inc. Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today anno...
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
Enzo Biochem, Inc. - Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pione...
Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing
There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio of 1.3x is worth a mention when the median P/S for the Healthcare industry in the United States is very...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
